Poland - Pharmaceutical products

Description

The subject matter of the contract is supply of medicinal products, pharmaceutical raw materials and aflibercept under the drug program.2 The medicinal products offered by the Economic Operators in this procedure must meet the requirements resulting from the Act of 6 September 2001. Pharmaceutical Law (consolidated text in Journal of Laws of 2019, item 499 as amended).3. The pharmaceutical raw materials offered by the Economic Operators in this proceeding must meet the requirements arising from the Act of 6 September 2001. Pharmaceutical law (uniform text Dz.U. of 2019, item 499).
1. ballastina 20 mgl tabl, tbl 7200. 1. clobetasol 0.5 mg/g; tube a 30g; ointment op. 240; 2. clobetasol 0.5 mg/g; tube a 30g; cream op. 240. 1. betamethasone + salicylic acid 1 g contains 0.5mg of betamethasone and 20 mg of salicylic acid; liquid for stack shortening; op. a 100 ml op. 240. 1. diflucortolone + isoconazole 1 g contains: 10 mg isoconazole and 1 mg diflucortolone; cream; op. a 15 g op. 240. 1. clobetasol 05 mg/ml (0.05 %); skin solution; op. a 50 ml op. 240. 1. tacrolimus 0.1 %; ointment; op. a 30 g op. 240; 2. tacrolimus 0.3 %; ointment op. a 100 ml op. 240. and 30g op. 240. 1. betamethasone + gentamicin 1 g contains: 0.5 mg betamethasone and 1 mg gentamicin; ointment; op. a 30 g op. 240. 1. iodopovidone 5 %, eye drops, 30 ml capacity, target import op. Acidum lacticum formulation substance, packaging 100 ml or less, 900 ml 900;2 Cupri sulfas formulation substance, 1 g or less, 10;3 Ethacridini lactas formulation substance, 10 g or less, 100;4 Zinci sulfas heptahydricus formulation substance, 1 g or less, 10;1 Hydrargyri sulfuridum rubrum formulation substance, 10 g or less. Hydrargyrum aminochloratum formulation, packet not more than 25 g, g 200. Thymolum formulation, packet not more than 5 g, g 20. 1. Capsici tinctura normata formulation, packet not more than 100 ml, ml 300;2. Cinchonae tinctura formulation, packet not more than 100 ml, ml 300. Chlorhexidini diacetas formulation, packet. Not more than 1 g, g 5. 1. Unguentum cholesterol ointment medium, pack not less than 1 kg, kg 80;2. Vaselinum hydrophilicum ointment medium, pack not less than 0,5 kg, kg 80;3. Eucerinum ointment base, packaging not less than 1 kg, kg 120. 1. Neomycinum formulation, packaging not more than 25 g, g 75. 1. aphlibercept 40 mg/ml op. x 1 vial and 0,1 ml, 170.

Opportunity closing date

09 November 2020

Value of contract

to be confirmed